Connect with us

JAMMU & KASHMIR

Blood pressure medicines don’t increase risk of COVID: DAK | KNO

Published

on

kno news

Srinagar, June 01 (KNO): Doctors Association Kashmir (DAK) on Monday said blood pressure medicines do not increase the risk of infection, serious illness or death from the novel coronavirus. “It is perfectly safe to continue your blood pressure medication during the Covid pandemic,” said DAK President Dr Nisar-u-Hassan in a statement issued to news agency—Kashmir News Observer (KNO) “People have apprehensions that ACE inhibitors and ARBs, two classes of drugs that are widely prescribed for high blood pressure increase the risk of Covid infection and the likelihood of severe illness among those infected with the novel virus,” he said. “ACE inhibitors include enalapril, lisinopril, captopril and other drugs with generic names ending in –pril; ARBs include Losartan, telmisartan, olmesartan and other generic drugs ending in –sartan,” he added. Dr Nisar said speculations about worse outcomes among patients on these medications during the Covid pandemic have caused widespread anxiety among patients and their care providers. Quoting three studies published in New England Journal of Medicine, Dr Nisar said no link was found between the use of blood pressure drugs and coronavirus infection. “It was also revealed that patients on these drugs faced no increase in risk of becoming severely ill with Covid infection,” he added. Dr Nisar said the articles showed no association between use of the two classes of blood pressure drugs of concern and dying from COVID-19. “In fact, some studies suggest that these drugs might reduce lung injury in people infected with the novel virus,” he said. Dr Nisar said it is vitally important to keep your blood pressure well controlled and take medication as advised. “Having high blood pressure has been associated with higher rate of dying from Covid-19,” he said. “People should stick with their blood pressure medication because high blood pressure is a risk factor for heart attack, stroke and kidney failure,” said Dr Nisar –(KNO)

Trending

TOP STORIES1 hours ago

The Natural Farming Revolution India Needs | KNO

TOP STORIES3 hours ago

Met predicts wet weather across J&K till Aug 7, heavy showers in Jammu division | KNO

TOP STORIES3 hours ago

J&K records 1,109 highway accidents, 206 deaths in 2026: Centre | KNO

TOP STORIES3 hours ago

Amarnath Yatra: Day 28: 5,211 pay obeisance at holy cave shrine, 4.46 lakh devotees complete pilgrimage till date | KNO

TOP STORIES3 hours ago

Lying face-down for 415 days: UP man takes up extraordinary journey to Amarnath cave shrine | KNO

TOP STORIES3 hours ago

Jmu-Sgr Highway to remain closed tomorrow, commuters advised to avoid travel | KNO

TOP STORIES3 hours ago

Pellet victim Insha gets LPG agency after 9-year wait, urges ban on lethal weapons | KNO

TOP STORIES3 hours ago

Centre committed to develop unexplored tourist destinations in Kupwara: Shekhawat informs Rajya Sabha | KNO

TOP STORIES3 hours ago

J&K road fatalities rise from 774 in 2021 to 984 in 2025; 603 deaths this year so far | KNO

TOP STORIES3 hours ago

518 lakes disappeared or shrunk in J&K: Centre says CAG assessment based on satellite imagery | KNO

TOP STORIES3 hours ago

J&K gets 2 cold chain projects under PMKSY worth ₹18.15 crore | KNO

TOP STORIES3 hours ago

‘J&K has 12.75 lakh ST population, Ladakh 2.18 lakh as per Census 2011’ | KNO

TOP STORIES3 hours ago

J&K gets Rs 10,528 cr for national highways in 2023-24, Ladakh Rs 658 cr: Centre | KNO

TOP STORIES3 hours ago

Centre has not assessed climate change impact on Changpa Community in Ladakh: Tribal Affairs Ministry | KNO

TOP STORIES3 hours ago

Police attach properties of 5 Pak based terror handlers in Reasi | KNO

TOP STORIES3 hours ago

CONNECTIVITY WOES: Bridgeless Bagandar: Tral residents seek permanent link | KNO

TOP STORIES3 hours ago

EOW Kashmir files chargesheet, books four in fake cooking oil company fraud | KNO

Copyright © 2021